Project Grant HT94252410466
Award Date
10/1/24
Completion Date
9/30/26
Dollars Obligated
$320K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10016, USA
Similar Awards
This $949,181 federal Project Grant award was provided by the U.S. Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund research by the Icahn School of Medicine at Mount Sinai to investigate the association between cortical lesions and physical/cognitive disability in multiple sclerosis using novel, clinically feasible MRI methods. The research aims to advance the understanding and treatment of multiple sclerosis, a...
New York University School of Medicine was awarded a $762,750 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund a research project titled "BEYOND VEXAS AND UBA1: IDENTIFICATION OF NOVEL DRIVERS OF MDS AUTOIMMUNE SYNDROMES" from June 15, 2023 through June 14, 2026. The grant supports research to identify novel drivers of myelodysplastic syndromes, blood disorders that can progress...
The Defense Health Agency awarded a $1,694,245 Project Grant to New York University (NYU) School of Medicine, a private non-profit research institution and medical school, to develop innovative therapeutics against pressure ulcer-associated bacteria. The 4-year grant, which runs from August 2023 to August 2027, is funded under the Military Medical Research and Development program (CFDA 12.420). Through this award, NYU School of Medicine will conduct research to identify and advance new...
The Department of the Army Medical Command awarded New York University School of Medicine a $1,186,500 project grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through August 2024 to understand the transition from nevi to melanoma occurring within the skin epidermis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military...
This federal Project Grant award of $320,000.00 from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) supports a research project titled "MULTIPLE SCLEROSIS DISPARITIES: EVALUATION OF CHRONIC STRESS LOAD AND SOCIAL FACTORS". The award, effective September 30, 2024 through September 29, 2026, has been transferred from Johns Hopkins University to The Washington University in St. Louis. The project aims to advance research on...
The U.S. Department of Defense's Defense Health Agency awarded a $319,204 Project Grant to the Icahn School of Medicine at Mount Sinai (ISMMS) to conduct research on "Advanced Brain Age Modeling in Multiple Sclerosis: Toward a Prognostic Biomarker for Personalized Medicine." The award, which runs from August 15, 2024, to August 14, 2026, is part of the Military Medical Research and Development program (CFDA 12.420). This program supports biomedical research initiatives aimed at...
New York University School of Medicine was awarded a $911,777 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research into Mitochondrial Dynamics as a Therapy Target in Myelodysplastic Syndromes. Through September 2025, NYU School of Medicine researchers will investigate medical solutions for blood cancers like MDS by exploring mitochondrial functions and their potential as...
This federal Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support the "DEVELOPMENT OF INNOVATIVE THERAPEUTICS AGAINST PRESSURE ULCER-ASSOCIATED BACTERIA" at New York University School of Medicine. The $1,695,467.00 award, active from August 15, 2023 to August 14, 2027, will fund research to develop innovative treatments against bacteria associated with pressure ulcers. As a private...
The federal Project Grant award of $249,612.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award is funding research by Yale University to unravel the causal impact of multiple sclerosis (MS)-associated genetic variants on T cell immune tolerance. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing the understanding of MS pathogenesis through...
This federal Project Grant award of $2,278,276.00 from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) will fund research by New York University (NYU) to optimize psychological health and prevent clinical problems. The three-year project will test the effectiveness of an evidence-based toolkit for integrated operational support. NYU has extensive experience conducting federal grant-funded research across a range of domains,...